中国医学创新2016，Vol.13Issue(16)：32-34,35,4.DOI:10.3969/j.issn.1674-4985.2016.16.009
心肌酶和NT-proBNP对肝炎肝硬化并心肌损害的临床价值分析
The Clinical Value Analysis on Myocardial Enzymes and NT-proBNP in Liver Cirrhosis and Myocardial Damage
摘要
Abstract
Objective:To explore the value analysis on myocardial enzymes and N end-B type brain natriuretic peptide precursor (NT-proBNP) in virus liver cirrhosis and myocardial damage.Method:From September 2013 to October 2015,60 cases of hepatitis B in our hospital were selected as the research objects, they were divided into the chronic hepatitis group of 35 cases and the liver cirrhosis group of 25 cases,another 26 cases of healthy people at the same period were selected as the control group,routine ECG examination,creatine kinase (CK),creatine kinase isoenzyme (CKMB),super sensitive troponin T (hs-TNT) and NT-proBNP were measured.Result:There were statistically significant differences between three groups in electrocardiographic abnormality(P<0.05).There were no significant differences in chronic hepatitis group and liver cirrhosis group with CK-MB,chronic hepatitis group and control group with NT-proBNP (P>0.05),the differences of CK,hs-TNT and NT-proBNP between three groups were statistically significant (P<0.05).Conclusion:Myocardial injury can occur in patients with hepatitis B,but the myocardial injury in patients with cirrhosis was more serious and combined potential cardiac insufficiency.关键词
病毒性肝炎/心肌酶谱/N端-B型脑钠肽前体Key words
Viral hepatitis/Myocardialase spectrum/N end-B type brain natriuretic peptide precursor引用本文复制引用
张志,候宪云,张扬立..心肌酶和NT-proBNP对肝炎肝硬化并心肌损害的临床价值分析[J].中国医学创新,2016,13(16):32-34,35,4.基金项目
2015年广州市产学研协同创新重大专项民生科技项目 （）
